220 related articles for article (PubMed ID: 30307603)
1. Clinical trials involving carbon-ion radiation therapy and the path forward.
Lazar AA; Schulte R; Faddegon B; Blakely EA; Roach M
Cancer; 2018 Dec; 124(23):4467-4476. PubMed ID: 30307603
[TBL] [Abstract][Full Text] [Related]
2. Hadrontherapy for cancer. An overview of HTA reports and ongoing studies.
Jefferson T; Formoso G; Venturelli F; Vicentini M; Chiarolla E; Ballini L
Recenti Prog Med; 2019 Dec; 110(12):566-586. PubMed ID: 31909760
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
4. Health Technology Assessment of Carbon-ion Beam Radiotherapy: A Systematic Review of Clinical Effectiveness and Safety for 54 Oncological Indications in 12 Tumour Regions.
Goetz G; Mitic M; Mittermayr T; Wild C
Anticancer Res; 2019 Apr; 39(4):1635-1650. PubMed ID: 30952702
[TBL] [Abstract][Full Text] [Related]
5. Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial.
Kong L; Gao J; Hu J; Lu R; Yang J; Qiu X; Hu W; Lu JJ
Cancer Commun (Lond); 2019 Feb; 39(1):5. PubMed ID: 30786916
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the role of carbon ion radiation therapy in recurrent rectal cancer.
Venkatesulu BP; Giridhar P; Malouf TD; Trifletti DM; Krishnan S
Acta Oncol; 2020 Oct; 59(10):1218-1223. PubMed ID: 32476538
[TBL] [Abstract][Full Text] [Related]
7. A protocol for a randomized trial evaluating the role of carbon-ion radiation therapy plus camrelizumab for patients with locoregionally recurrent nasopharyngeal carcinoma.
Hu J; Huang Q; Hu W; Gao J; Yang J; Zhang H; Lu JJ; Kong L
Cancer Med; 2024 Feb; 13(3):e6742. PubMed ID: 38205914
[TBL] [Abstract][Full Text] [Related]
8. Clinical Indications for Carbon Ion Radiotherapy.
Mohamad O; Yamada S; Durante M
Clin Oncol (R Coll Radiol); 2018 May; 30(5):317-329. PubMed ID: 29402598
[TBL] [Abstract][Full Text] [Related]
9. A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma.
Vogin G; Wambersie A; Koto M; Ohno T; Uhl M; Fossati P; Balosso J;
Radiat Oncol; 2019 Feb; 14(1):24. PubMed ID: 30709366
[TBL] [Abstract][Full Text] [Related]
10. Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.
Mishra MV; Aggarwal S; Bentzen SM; Knight N; Mehta MP; Regine WF
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):228-235. PubMed ID: 28068231
[TBL] [Abstract][Full Text] [Related]
11. Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma.
Apisarnthanarax S; Bowen SR; Combs SE
Semin Radiat Oncol; 2018 Oct; 28(4):309-320. PubMed ID: 30309641
[TBL] [Abstract][Full Text] [Related]
12. FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy.
Darwis NDM; Nachankar A; Sasaki Y; Matsui T; Noda SE; Murata K; Tamaki T; Ando K; Okonogi N; Shiba S; Irie D; Kaminuma T; Kumazawa T; Anakura M; Yamashita S; Hirakawa T; Kakoti S; Hirota Y; Tokino T; Iwase A; Ohno T; Shibata A; Oike T; Nakano T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540114
[TBL] [Abstract][Full Text] [Related]
13. Impact of carbon ion radiotherapy for primary spinal sarcoma.
Matsumoto K; Imai R; Kamada T; Maruyama K; Tsuji H; Tsujii H; Shioyama Y; Honda H; Isu K;
Cancer; 2013 Oct; 119(19):3496-503. PubMed ID: 23939877
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
[TBL] [Abstract][Full Text] [Related]
15. Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma.
Byun HK; Kim C; Seong J
Clin Mol Hepatol; 2023 Oct; 29(4):945-957. PubMed ID: 37583055
[TBL] [Abstract][Full Text] [Related]
16. Carbon-ion radiotherapy for patients with advanced stage non-small-cell lung cancer at multicenters.
Karube M; Yamamoto N; Shioyama Y; Saito J; Matsunobu A; Okimoto T; Ohno T; Tsuji H; Nakano T; Kamada T
J Radiat Res; 2017 Sep; 58(5):761-764. PubMed ID: 28992088
[TBL] [Abstract][Full Text] [Related]
17. An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia.
Ahern V; Adeberg S; Fossati P; Garrett R; Hoppe B; Mahajan A; Orlandi E; Orecchia R; Prokopovich D; Seuntjens J; Thwaites D; Trifiletti D; Tsang R; Tsuji H
Radiother Oncol; 2023 Oct; 187():109816. PubMed ID: 37480996
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC).
Cavalieri S; Vitolo V; Barcellini A; Ronchi S; Facoetti A; Campo C; Klersy C; Molinelli S; Agustoni F; Ferretti VV; Silvestri A; Platania M; Del Vecchio M; Durante M; Helm A; Fournier C; Braud F; Pedrazzoli P; Orlandi E; Licitra L
Future Oncol; 2023 Jan; 19(3):193-203. PubMed ID: 36974574
[TBL] [Abstract][Full Text] [Related]
19. Salvage surgery for local recurrence after carbon ion radiotherapy for patients with lung cancer.
Mizobuchi T; Yamamoto N; Nakajima M; Baba M; Miyoshi K; Nakayama H; Watanabe S; Katoh R; Kohno T; Kamiyoshihara M; Nishio W; Kamada T; Fujisawa T; Yoshino I
Eur J Cardiothorac Surg; 2016 May; 49(5):1503-9. PubMed ID: 26468271
[TBL] [Abstract][Full Text] [Related]
20. The Role of Carbon Ion Therapy in the Changing Oncology Landscape-A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy.
Orlandi E; Barcellini A; Vischioni B; Fiore MR; Vitolo V; Iannalfi A; Bonora M; Chalaszczyk A; Ingargiola R; Riva G; Ronchi S; Valvo F; Fossati P; Ciocca M; Mirandola A; Molinelli S; Pella A; Baroni G; Pullia MG; Facoetti A; Orecchia R; Licitra L; Vago G; Rossi S
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
